In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. In the recent Federal Circuit decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS ...
Patent Issued for Method For Using Electronic Metadata To Verify Insurance Claims (USPTO 10,650,464)
The method of claim 1, wherein the physical token is an identification card. “5. The method of claim 1, wherein the physical token is a state issued driver’s license. “6. The computer implemented ...
The Federal Circuit’s recent decision in United Therapeutics Corp. v. Liquidia Techs., Inc., No. 2022-2217, 2023 WL 4695903 (Fed. Cir. July 24, 2023), provides an interesting discussion on the written ...
“The insurance claim may comprise any of a claim against one or more of a health insurance, a worker compensation insurance, a liability insurance, a homeowner’s insurance, a property casualty ...
Molecular biomarkers, such as variations in genetic sequences, protein levels, or combinations of specific biochemical changes, are increasingly important to the emergence of personalized medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results